Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone cream to reduce hypertrophic and keloid scars after tunneled central venous catheter removal in childhood cancer survivors
2009-015163-14Phase 3Completed
- Sponsor
- Aarhus University Hospital, Department of Pediatrics
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of betamethasone in Hypertrophic Scar (HS) and keloid (2 arms), sponsored by Aarhus University Hospital, Department of Pediatrics. Primary endpoint: Vancouver Scar Scale score at 12 months. Started Nov 2009; status: completed.
02
Drugs
betamethasone
03
Conditions
Hypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on 2009-015163-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015163-14.